Gal beta(1-4)[Neu5Ac alpha(2-6)]GlcNAc-beta-pNP>90.0%(HPLC)2mg

N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide, 98%, 100g

3-(2-Methyl-pyridin-4-yl)-propan-1-ol, 98%, 1g

5-Bromo-3-chloro-2-hydroxybenzonitrile, 98%, 250mg

Methyl-2,3-O-isopropylidene-D-ribofuranoside, 95.0%, 25g

4-Chlorobenzoyl isothiocyanate, 97.0%, 1g

2-(5-methoxy-1H-indol-3-yl)-2-[3-(trifluoromethyl)phenyl]ethanamine, 250mg

7-chloro-5,6-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine, 95.0%, 250mg

[1-(2-Chloro-pyridine-3-carbonyl)-piperidin-3-ylmethyl]-carbamic acid tert-butyl ester, 95.0%, 250mg

(+)-Borneol, ROTICHROM® GC, 100 mg, plastic packaging.

3,3-DIMETHYL-5-NITROINDOLINE, 97.0%, 1g

2-Bromo-9,9-dimethylfluorene>98.0%(GC)25g

2-Amino-4-chloropyridine, 98.0%, 25g